EFG Asset Management’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-20,705
Closed -$3.25M 196
2024
Q3
$3.25M Sell
20,705
-491
-2% -$75.7K 0.54% 53
2024
Q2
$3.19M Buy
21,196
+2,343
+12% +$281K 0.55% 54
2024
Q1
$1.39M Buy
18,853
+6,213
+49% +$512K 0.24% 165
2023
Q4
$998K Sell
12,640
-314
-2% -$18.9K 0.19% 176
2023
Q3
$709K Buy
12,954
+2,544
+24% +$183K 0.17% 172
2023
Q2
$874K Buy
+10,410
New +$797K 0.19% 167

Other funds holding TMDX

EFG Asset Management's TMDX Position: Q4 2024 in Review

EFG Asset Management sold out of Transmedics (TMDX) in Q4 2024, closing a stake of 20,705 shares — an estimated $3.25M sold.

EFG Asset Management first reported a position in TMDX in Q2 2023 and held it in 6 quarters. The position peaked at $3.25M in Q3 2024. 315 funds tracked by Wall St. Rank hold TMDX as of Q4 2024.

  • EFG Asset Management reported no remaining Transmedics position as of Q4 2024 after selling out during the quarter.
  • EFG Asset Management sold 20,705 Transmedics shares in Q4 2024, an estimated $3.25M.
  • EFG Asset Management first reported a position in Transmedics in Q2 2023 and held it in 6 quarters.
  • EFG Asset Management's Transmedics position peaked at $3.25M in Q3 2024.
  • 315 funds tracked by Wall St. Rank held Transmedics as of Q4 2024.

Based on EFG Asset Management's 13F filing for Q4 2024, filed 11 Feb 2025.